A recent study reported that METTL1 triggers osteosarcoma cells ferroptosis via the miR-26a/FTH1 axis which in turn induces iron death and increases the sensitivity of osteosarcoma cells to chemotherapeutic agents [38]. This evidence concerns the gene METTL1 and osteosarcoma.